EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,428,000 | -31.4% | 284,988 | -28.8% | 0.08% | +3.8% |
| Q1 2021 | $3,540,000 | -28.0% | 400,000 | 0.0% | 0.08% | -32.5% |
| Q4 2020 | $4,916,000 | +34.4% | 400,000 | -11.0% | 0.12% | -17.0% |
| Q3 2020 | $3,659,000 | -45.6% | 449,510 | -35.8% | 0.14% | -44.9% |
| Q2 2020 | $6,720,000 | +21.2% | 700,000 | -14.1% | 0.26% | -0.8% |
| Q1 2020 | $5,543,000 | -55.4% | 815,127 | -2.2% | 0.26% | -48.0% |
| Q4 2019 | $12,418,000 | +21.4% | 833,400 | -16.5% | 0.50% | -20.4% |
| Q3 2019 | $10,228,000 | -16.1% | 997,892 | -13.2% | 0.62% | -11.0% |
| Q2 2019 | $12,190,000 | – | 1,150,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |